Audit 363359

FY End
2024-12-31
Total Expended
$48.69M
Findings
0
Programs
37
Organization: Ahs Hospital Corp. (NJ)
Year: 2024 Accepted: 2025-07-30

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
21.027 Covid-19 Coronavirus State Fiscal Recovery Fund Project 2024 $35.00M Yes 0
21.027 Covid-19 Western Region Plant Modernization $2.47M Yes 0
93.493 Community Project Funding/congressional Directed Spending - Construction $928,863 - 0
97.036 Covid-19 Federal Emergency Management Disaster Relief Public Assistance $872,289 - 0
93.399 Cancer Control $706,593 - 0
93.914 Ryan White Part A Hiv Emergency Relief Grant Program 2025 $482,610 - 0
17.268 H-1b Job Training Grants $479,544 - 0
93.116 Tuberculosis Ambulatory Care 2024 $151,823 - 0
84.181 Early Intervention Program $143,264 - 0
93.898 New Jersey Cancer Education and Early Detection 2025 $130,103 - 0
93.940 Dhsts Federal Hiv Prevention Program 2023 $115,964 - 0
97.067 Ffy21 Urban Areas Security Initiative (uasi-Local Share) $114,305 - 0
93.914 Ryan White Part A Hiv Emergency Relief Grant Program 2024 $112,261 - 0
20.600 Hts Federal Highway Safety Grant 2024 Morris County Safe Communities $75,044 - 0
93.898 New Jersey Cancer Education and Early Detection 2024 $71,655 - 0
93.497 Covid-19 Sexual Violence Direct Services $70,661 - 0
93.394 MD Anderson Cancer Center Edrn- Clinical Validation Center for Early Detection of Ovarian Cancer with A Multiple Marker Algorithm (00015459) $48,750 - 0
16.575 Sexual Assault Response Team (sart)/forensic Nurse Examiner (fne) $36,167 - 0
93.994 Special Child Health Case Management 2024 $33,226 - 0
93.994 Special Child Health Case Management 2025 $31,205 - 0
93.994 Special Child Health Child Evaluation Centers 2024 $31,179 - 0
93.394 Nuvox Aiken Restore-P2, Randomized Prospective Phase II Clinical Trial of Nvx-108 in Association with Chemoradiation of Glioblastoma $29,357 - 0
20.600 Hts Federal Highway Safety Grant 2025 Morris County Safe Communities $21,790 - 0
93.994 Special Child Health Child Evaluation Centers 2025 $21,317 - 0
93.399 Wake Forest Ncorp Research Base $21,000 - 0
93.395 Nih Cog/phi Nctn (ar07544) $19,575 - 0
97.067 Ffy22 Urban Areas Security Initiative (uasi-Local Share) $18,671 - 0
21.027 Covid-19 Sexual Violence Direct Services $10,671 Yes 0
93.847 Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed with Crohn's Disease (cameo) $5,350 - 0
93.958 Covid-19 Peer Support $5,153 - 0
93.855 Comparative Effectiveness and Complications of Intravenous Ceftriaxone Compared with Oral Doxycycline in Lyme Meningitis $3,944 - 0
93.399 Alliance Ncorp Research Base Service Agreement with Alliance Nctn Foundation (anf) $3,000 - 0
93.855 Effect of Il-4rar576 Variant on Response to Dupilumab in Children with Asthma (idea) $1,818 - 0
93.837 Clinical, Electrocardiographic & Cardiac Magnetic Resonance Imaging Risk Factors Associated with Ventricular Tachyarrhythmias in Nonischemic Cardiomyopathy/urf (awd00002150) $1,260 - 0
84.181 Covid-19 Early Intervention Program $936 - 0
93.847 Type 1 Diabetes Trialnet $510 - 0
93.399 Nrg-Cc005 Forte $300 - 0

Contacts

Name Title Type
CBEMLJBKLZB4 Katharine Driebe Auditee
9734512027 Kate Corgel Auditor
No contacts on file

Notes to SEFA

Title: COVID-19 Department of Homeland Security Federal Emergency Management Agency (FEMA) Accounting Policies: The information on the Schedule of Expenditures of Federal Awards (the "Federal Schedule") is reported on the accrual basis of accounting and is presented in accordance with the requirements of the Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (“Uniform Guidance”). Therefore, some amounts presented in this Federal Schedule may differ from amounts presented in or used in preparation of the basic consolidated financial statements. The purpose of the Federal Schedule is to present a summary of those activities of the Hospital for the year ended December 31, 2024 which have been funded by the federal government. For purposes of the Federal Schedule, federal awards include any assistance provided by a federal agency directly or indirectly in the form of grants, contracts and loans and loan guarantees. The Hospital does not receive any assistance in the form of loans or loan guarantees. Direct and indirect costs are charged to awards in accordance with cost principles contained in the Department of Health and Human Services (“DHHS”), U.S. Office of the Assistant Secretary Comptroller (“OASC”), OASC-3, A Guide for Hospitals. Under these cost principles, certain types of expenditures are not allowable or are limited as to reimbursement. Because the Federal Schedule presents only a selected portion of the activities of the Hospital, it is not intended to, and does not present the consolidated financial position, results of operations, changes in net assets or cash flows of the Hospital. Full Assistance Listing Numbers (“ALN”) and pass-through entity numbers are included when available. While certain awards on the Federal Schedule have program names identified as award year 2023 and 2025, only expenses incurred during the year ended December 31, 2024 are reported on the Federal Schedule. These awards have grant periods that do not align with the Hospital’s calendar year end. De Minimis Rate Used: N Rate Explanation: Indirect costs are recovered at the lower of the rate specified under the grant agreement or the Hospital’s approved indirect cost rate of 55%, rather than the allowed de minimus rate. For the year ended December 31, 2024, the Hospital recorded $872,289 of claims to FEMA under ALN 97.036. The claims submitted represented incurred eligible operating expenses attributed to the Hospital’s response to COVID-19, which were not only expended, but also approved by the federal and state agencies. The Hospital has additional claims outstanding and under review with FEMA as of December 31, 2024 which will be recognized in the year the related funds are approved by FEMA at the federal and state agencies.